ADC Therapeutics SA EBITDA Margin 2019-2023 | ADCT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ADC Therapeutics SA (ADCT) over the last 10 years. The current EBITDA margin for ADC Therapeutics SA as of March 31, 2023 is .
|ADC Therapeutics SA EBITDA Margin Historical Data
||Medical - Biomedical and Genetics
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.